Bromberg, Kenneth D.
AbbVie (United States)
2 papers on CoChat
Most cited papers
- Verified
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Lasko, L. M., Jakob, C. G., Edalji, R. P., Qiu, W., Montgomery, D., Digiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R., Manaves, V., et al. (2017) · Nature
Histone Deacetylase Inhibitors ResearchProtein Degradation and Inhibitors
Cited by 858
- Verified
Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition
Hogg, S. J., Motorna, O., Cluse, L. A., Johanson, T. M., Coughlan, H. D., Raviram, R., Myers, R. M., Costacurta, M., Todorovski, I., Pijpers, L., et al. (2021) · Molecular Cell
Genomics and Chromatin DynamicsEpigenetics and DNA Methylation
Cited by 170
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free